Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$4.44
Net Income/Share$-8.57
Operating CF/Share$-13.47
Free CF/Share$-13.51
Cash/Share$19.18
Book Value/Share$6.04
Tangible Book/Share$6.04
Equity/Share$6.04
Interest Debt/Share$8.41
CapEx/Share$0.04
Dividend/Share$0.00
Valuation
Market Cap$759.35M
Enterprise Value$810.23M
P/E Ratio-4.36P/S Ratio12.13P/OCF Ratio-2.77
P/FCF Ratio-3.99
P/B Ratio6.18P/TB Ratio6.18
EV/Sales12.94EV/EBITDA-9.36
Graham Valuation
Graham Number--
Graham Net-Net$3.90
Profitability
Earnings Yield-22.96%FCF Yield-25.07%ROE-356.81%ROIC-38.00%Return on Tangible Assets-40.07%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.32%
CapEx/Revenue0.98%
CapEx/Depreciation2.05
SBC/Revenue24.38%
SG&A/Revenue119.21%
R&D/Revenue185.88%
Liquidity & Solvency
Debt/Equity1.08Debt/Assets0.31Debt/Market Cap0.12
Net Debt/EBITDA-0.59
Current Ratio4.24Interest Coverage-3.69xIncome Quality1.57Efficiency
Days Sales Outstanding8 days
Days Payables Outstanding712 days
Days Inventory0 days
Receivables Turnover48.56x
Payables Turnover0.51x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$85.09M
Working Capital$215.02M
Invested Capital$225.01M
Intangibles/Assets0.00%